Antipyretic and analgesic activities of Caesalpinia bonducella seed kernel extract

Phytotherapy Research

Volumn 19, Issue 5, 2005, Pages 376-381

  Archana, P ^a   Tandan, S K ^a   Chandra, S ^a   Lal, J ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Antinociceptive; Antipyretic; Caesalpinia bonducella

Indexed keywords

ACETIC ACID; CAESALPINIA BONDUCELLA PLANT EXTRACT; FORMALDEHYDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ANTIPYRETIC ACTIVITY; ARTICLE; CAESALPINIA; CONTROLLED STUDY; FEMALE; FEVER; HOT PLATE TEST; LICKING; MALE; MOUSE; NONHUMAN; PAIN; RAT; SACCHAROMYCES CEREVISIAE; SEED KERNEL; TAIL FLICK TEST; WRITHING TEST;

ACETIC ACID; ADMINISTRATION, ORAL; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANIMALS; BODY TEMPERATURE; CAESALPINIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORMALDEHYDE; HEAT; MALE; MICE; PAIN; PAIN MEASUREMENT; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS;

CAESALPINIA BONDUCELLA;

EID: 24644436861     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1339     Document Type: Article

References (44)

1. Balmain A, Bjamer K, Cannoly JD, Ferguson G. 1967. The constitution and sterochemistry of ε-Caesalpin. Tetrahedron Letts 49: 5027-5031.
2. Berkenkopf JW, Weichman BM. 1988. Production of prostacyclin in mice following intraperitoneal injection of acetic acid, phenylbenzoquinone and zymosan: its role in the writhing response. Prostaglandins 36: 693-709.
3. Calixto JB, Beirith A, Ferreira J, et al. 2000. Naturally occurring antinociceptive substances from plants. Phytother Res 14: 401-418.
4. Canonica L, Jommi G, Manitto P, Pelizzoni F. 1963. Bitter principles of Caesalpinia bonducella. Tetrahedron Letts 29: 2079-2086.
5. Cao C, Matsumura K, Yamagata K, Watanabe Y. 1996. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: A possible site of prostaglandin synthesis responsible for fever. Brain Res 733: 263-272.
6. Chapman CR, Casey KL, Dubner R, et al. 1985. Pain measurement: an overview. Pain 22: 1.
7. Chatterjee A, Pakrashi SC. 1992. Caesalpinia bonduc (L.) Roxb. In The Treatise on Indian Medicinal Plants 2. CSIR: New Delhi; 27-29.
8. Chopra RN, Chopra IC, Handa KL, Kapur LD. 1958. Caesalpinia bonducella. In Indigenous Drugs of India, 2nd edn. UN Dhur & Sons Pvt. Ltd: Calcutta; 304-305.
9. Clark WG, Cumby HR. 1975. The antipyretic effect of indomethacin. J Physiol 248: 625-638.
10. Coderre TJ, Melzack R. 1992. The contribution of excitatory aminoacids to central sensibilization and persistent nociception after formalin-induced tissue injury. J Neuroscience 12: 3665-3670.
11. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110: 193-198.
12. Correa CR, Kyle DJ, Chakraverty S, Calixto JB. 1996. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol 117: 552-558.
13. D'Amour GE, Smith, DL. 1941. A method for determining loss of pain sensation. J Pharmacol Exp Ther 72: 74-79.
14. Damas J, Liegeois JF. 1999. The inflammatory reaction induced by formalin in rat paw. Naunyn Schmiedebergs Arch Pharmacol 359: 200-207.
15. Dubinsky B, Gebre-Mariam S, Capetola RJ, Rosenthale ME 1987. The analgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 20: 50-60.
16. Eddy NB, Leimbach D. 1953. Systemic analgesics II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 107: 385-393.
17. Evans WC. 1996. Trease and Evans 'Pharmacognosy', 14 edition. WB Saunders: London.
18. Fatima N, Chatterjee RK. 1989. Proc. of IX Nat. Cong. Parasit, Ujjain, abstract B-30, p. 27.
19. Hirose K, Jyoyama H, Kojima Y, et al. 1984. Pharmacological properties of 2-[44-(2-triazolyloxy)-phenyl] propionic acid (480156-5), a new non-steroidal anti-inflammatory agent. Arzneim. Forsch/Drug Res 34: 280-286.
20. Hunskaar S, Hole K. 1987. The formalin test in mice: dissociation between inflammatory and non-inflamatory pain. Pain 30: 103-114.
21. Iyengar MA, Pendse GS. 1965. Antidiarrhoeal activity of the nut of Caesalpinia bonducella (Flem). Indian J Pharm 27: 307-308.
22. Kirtikar KR, Basu BD. 1933. Caesalpinia crista Linn. In Indian Medicinal Plants 2. CSIR: New Delhi; 842-845.
23. Lewis J, Mansour A, Khachaturian H, et al. 1987. Opiods and pain regulation. In Pain and Headache, Vol. 9. Neurotransmitters and Pain Control. Karger, Basil; 129.
24. Loux JJ, Depalma PD, Yankell SL. 1972. Antipyretic testing of aspirin in rats. Toxicol Appl Pharmacol 22: 672-675.
25. Murthy RK, Fatima N, Kulshreshtha DK, Chatterjee RK. 1993. Proc. of III Asian Cong. of Parasitol., CDRI, Lucknow, Abstract PS-2-45, 113.
26. Nadkarni KM. 1954. Caesalpinia bonduc, Roxb. In Indian Materia Medica, 93rd edn. 1. Popular Book Depot: Bombay; 226-231.
27. Neogi NC, Nayak KP. 1958. Biological investigation of Caesalpinia bonducella Flem. Indian J Pharm 20: 95-100.
28. Pascoe KO, Burke BA, Chan WR. 1986. Caesalpin FA new furanoditerpene from Caesalpinia bonducella. J Nat Products 49: 913-915.
29. Puratchikody A, Jaswant A, Volarmathi R, Ruckmani K. 2000. Antipyretic activity of dried leaf extract of Caesalpinia purcherrima. Indian Drug 37 (11): 551-552.
30. Purushothaman KK, Kalyani K, Subramaniam K, Shanmuganathan SP. 1982. Structure of bonducellin, a new homoisoflavone from Caesalpinia bonducella. Indian J Chem 21B: 383.
31. Randall LO, Selitto JJ. 1957. A method for measurement of analgesic activity of inflammed tissue. Arch Int Pharmacodynamie 111: 409-419.
32. Schzwartz JI, Chan CC, Mukhopadhyay S, et al. 1999. Cyclooxygenase-2 inhibition by refecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 65: 653-660.
33. Shibata M, Ohkubo T, Takahashi H, Inoki R. 1989. Modified formalin test: Characteristic biphasic pain response. Pain 38: 347-352.
34. Siegmund E, Cadnus R, Lu G. 1957. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol 95: 729-731.
35. Snedecor GW, Cochran WG. 1989. In Statistical Methods, 19th edn. Iowa Press: Iowa.
36. Srinivasan K, Muruganandan S, Lal J, et al. 2001. Evaluation of anti-inflammatory activity of Pongania pinnata leaves in rats. J Ethno Pharmacol 78: 151-157.
37. Steranka LR, Dehaas CJ, Vavrek RJ, et al. 1987. Antinociceptive effects of bradykinin antagonist. Eur J Pharmacol 136: 261-262.
38. Stone CA, Wenger HC, Ludden CT, et al. 1961. Antiserotonin-antihistamic properties of cyproheptadine. J Pharmacol Exp Ther 131: 73-84.
39. Watt JM, Breyer-Brandwijk MG. 1962. The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd edn. Churchill Livingstone: Edinburgh; 562-564.
40. 50) and instruction in their use. Biometrics 8: 249-263.
41. Whittle BA. 1964. The use of changers in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics. Br J Pharmacol 22: 246-253.
42. Winter CA, Flataker L. 1965. Nociceptive thresholds as affected by parenteral administration of irritants and of various nociceptive drugs. J Pharmacol Exp Ther 148: 373-379.
43. Witkin LB, Hebner CF, Gaddi F, et al. 1961. Pharmacology of 2, amino-indane hydrochloride (SU-86029). A potent non-narcotic analgesic. J Pharmacol Exp Ther 133: 400-408.
44. Zeil R, Krupp P. 1975. Effect on prostaglandin synthesis and antipyretic activity of non steroid anti-inflammatory drugs. In Temperature Regulation and Drug Action. Karger Basel S, Schonbaum E, Lomax P, Jacob J (eds). Karger, Basil; 233-241.